Live Breaking News & Updates on International Finance Facility For Immunisation Iffim

Stay updated with breaking news from International finance facility for immunisation iffim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A case for Covid-19 vaccine bonds in Africa


A case for Covid-19 vaccine bonds in Africa
By Oluwaseun Oguntuase on 10 February 2021
Mass vaccination remains one of the most successful, cost-effective public health interventions. Being vaccinated means individuals are not only protected from being infected themselves, they also cannot pass the infection onto other people, where it may cause severe disease. 
However, stopping the continued spread of pathogens in a population requires herd immunity, also known as population immunity. Herd immunity is the indirect protection from an infectious disease that happens when a population is immune, either through vaccination or immunity developed through previous infection.
Experts have warned that around 80-90% of specific populations must have Covid-19 immunity, either through prior infection or vaccination, to reach herd immunity, but seroprevalence studies suggest that less than 10 percent of people in most countries have been infected with Covid-19.  The World H ....

United States , Lagos State , South Africa , Grand Casablanca , South African , Moderna Covid , Biontech Covid , Al Omrane , Oluwaseun Oguntuase , World Health Assembly , Coalition For Epidemic Preparedness Innovations , Central American Bank , International Finance Corporation , Access Bank Plc , Sustainable Development At Lagos State University , European Investment Bank , International Finance Facility For Immunisation Iffim , Centre For Environmental , International Capital Market Association , Italian Development Bank , Industrial Development Corporation Of South Africa , American Development Bank , World Health Organisation , Nordic Investment Bank , Council Of Europe Development , African Union ,

COVAX ANNOUNCES ADDITIONAL DEALS TO ACCESS PROMISING COVID-19 VACCINE CANDIDATES; PLANS GLOBAL ROLLOUT STARTING Q1 2021


COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021
COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021
18 December 2020
Reading time:
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors
These agreements mean that all COVAX’s 190 participating and eligible economies will be able
to access doses to protect vulnerable groups in the first half of 2021. At least 1.3 billion donor-funded doses will be made available to 92 economies eligible for the Gavi COVAX AMC, targeting up to 20% population coverage by the end of the year. ....

United States , Hong Kong , United Kingdom , New Zealand , University Of Hong Kong , Hong Kong General , South Korea , Karina Gould , Seth Berkley , Ngozi Okonjo Iweala , Wendy Morton , John Nkengasong , Inge Ulstein , Richard Hatchett , Tedros Adhanom Ghebreyesus , Pascal Soriot , Astrazeneca Oxford , Paul Stoffels , Thomasb Cueni , Institut Pasteur Merck Themis , Adar Poonawalla , Jane Halton , Mesfin Teklu Tessema , University Of Queensland , Team Europeconfirmed , American Health Organisation ,